Links to 7 New HCV Articles

[Guest guest]

Pharmasset Hep C Data Wows Investors

TheStreet.com

By Adam Feuerstein 03/08/11 - 11:46 AM EST PRINCETON, NJ (TheStreet) --

Pharmasset(VRUS) shares are soaring on the release of new but very preliminary

data that hints at a breakthrough, all-oral cure for hepatitis C. Treatment with

two oral drugs ...

See all stories on this topic »

Drug Companies Appeal $500M Judgment in Nevada Hepatitis Trial

Becker's ASC Review

The patient behind the case, Henry Chanin, contracted hepatitis C in 2006 during

a routine procedure. His lawyers argued that the vials of propofol provided to

the clinic were too large for a single use and invited use for multiple

patients. ...

See all stories on this topic »

Tech Ticker

San Mercury News

Gilead Sciences's four-drug combination eliminated hepatitis C virus in patients

in an early-stage study, RBC Capital Markets analysts said. The findings support

an ongoing midstage study of the combination, the analysts, led by Yee

in San ...

See all stories on this topic »

Increased compensation for NHS tainted blood victims

BBC News

Welsh people who contracted hepatitis C from contaminated blood from the NHS

will receive extra compensation. Health Minister Hart said a one-off

payment will rise to £50000 for people with the most serious related diseases.

....

See all stories on this topic »

Hepatitis C from blood 'unlikely'

The Press Association

A hepatitis C sufferer who died after two liver transplant operations was " most

unlikely " to have contracted the virus from infected blood products, an official

inquiry has heard. Victor Tamburrini, from Glasgow, suffered liver failure and

died in ...

See all stories on this topic »

Pharmasset to Challenge Vertex Hepatitis C Treatment, BMO Says

Bloomberg

By Naomi Kresge - Tue Mar 08 14:57:24 GMT 2011 Pharmasset Inc. (VRUS)'s

experimental hepatitis C therapies may pose a challenge to treatments from

Vertex Pharmaceuticals Inc. (VRTX), based on trial results to be released in

late March, ...

See all stories on this topic »

High court ruling will establish groundwork for hepatitis outbreak trials

Las Vegas Review - Journal

Justices heard arguments over whether jurors should hear about other possible

causes for the hepatitis C among patients who underwent procedures at endoscopy

clinics in Southern Nevada formerly owned by Dr. Dipak Desai. By Doug McMurdo

CARSON CITY ...

See all stories on this topic »

[Guest guest]

Pharmasset Hep C Data Wows Investors

TheStreet.com

By Adam Feuerstein 03/08/11 - 11:46 AM EST PRINCETON, NJ (TheStreet) --

Pharmasset(VRUS) shares are soaring on the release of new but very preliminary

data that hints at a breakthrough, all-oral cure for hepatitis C. Treatment with

two oral drugs ...

See all stories on this topic »

Drug Companies Appeal $500M Judgment in Nevada Hepatitis Trial

Becker's ASC Review

The patient behind the case, Henry Chanin, contracted hepatitis C in 2006 during

a routine procedure. His lawyers argued that the vials of propofol provided to

the clinic were too large for a single use and invited use for multiple

patients. ...

See all stories on this topic »

Tech Ticker

San Mercury News

Gilead Sciences's four-drug combination eliminated hepatitis C virus in patients

in an early-stage study, RBC Capital Markets analysts said. The findings support

an ongoing midstage study of the combination, the analysts, led by Yee

in San ...

See all stories on this topic »

Increased compensation for NHS tainted blood victims

BBC News

Welsh people who contracted hepatitis C from contaminated blood from the NHS

will receive extra compensation. Health Minister Hart said a one-off

payment will rise to £50000 for people with the most serious related diseases.

....

See all stories on this topic »

Hepatitis C from blood 'unlikely'

The Press Association

A hepatitis C sufferer who died after two liver transplant operations was " most

unlikely " to have contracted the virus from infected blood products, an official

inquiry has heard. Victor Tamburrini, from Glasgow, suffered liver failure and

died in ...

See all stories on this topic »

Pharmasset to Challenge Vertex Hepatitis C Treatment, BMO Says

Bloomberg

By Naomi Kresge - Tue Mar 08 14:57:24 GMT 2011 Pharmasset Inc. (VRUS)'s

experimental hepatitis C therapies may pose a challenge to treatments from

Vertex Pharmaceuticals Inc. (VRTX), based on trial results to be released in

late March, ...

See all stories on this topic »

High court ruling will establish groundwork for hepatitis outbreak trials

Las Vegas Review - Journal

Justices heard arguments over whether jurors should hear about other possible

causes for the hepatitis C among patients who underwent procedures at endoscopy

clinics in Southern Nevada formerly owned by Dr. Dipak Desai. By Doug McMurdo

CARSON CITY ...

See all stories on this topic »